Intravascular large B-cell lymphoma (IVLBCL): A clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5

Blood

Volumn 109, Issue 2, 2007, Pages 478-485

  Murase, Takuhei ^a   Yamaguchi, Motoko ^b   Suzuki, Ritsuro ^c   Okamoto, Masataka ^d   Sato, Yumiko ^e   Tamaru, Jun Ichi ^f   Kojima, Masaru ^g   Miura, Ikuo ^h   Mori, Naoyoshi ⁱ   Yoshino, Tadashi ^e   Nakamura, Shigeo ⁱ  

^a Nishio Municipal Hospital   (Japan)

^b MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e OKAYAMA UNIVERSITY   (Japan)

^f SAITAMA MEDICAL UNIVERSITY   (Japan)

^g GUNMA CANCER CENTER HOSPITAL   (Japan)

^h ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁱ NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; CD5 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN DERIVATIVE; HYDROXYDOXORUBICIN; PREDNISOLONE; PROTEIN BCL 2; PROTEIN BCL 6; RITUXIMAB; UNCLASSIFIED DRUG; VINCRISTINE;

ADULT; AGED; ANEMIA; ANTIGEN PRESENTATION; ARTICLE; B CELL LYMPHOMA; BONE MARROW DISEASE; CELL HETEROGENEITY; CHEMOTHERAPY; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG MEGADOSE; ERYTHROPHAGOCYTOSIS; FEMALE; HEPATOSPLENOMEGALY; HISTOPATHOLOGY; HUMAN; IMMUNOPHENOTYPING; INTRAVASCULAR LARGE BETA CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROGNOSIS; REMISSION; SURVIVAL; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 33846202429     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2006-01-021253     Document Type: Article

References (26)

1. Gatter KC, Warnke RA. Intravascular large B-cell lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization: Pathology and Genetics of Tumors of Heamatopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:177-178.
2. Pfleger VL, Tappeiner J. Zur Kenntnis der systemisierten Endotheliomatose der cutanen Blutgefaße (Reticuloendotheliose?). Hautarzt. 1959;10:363-369.
3. Murase T, Nakamura S, Tashiro K, et al. Malignant histiocytosis-like B-cell lymphoma, a distinct pathologic variant of intravascular lymphomatosis: a report of five cases and review of the literature. Br J Haematol. 1997;99:656-664.
4. Murase T, Nakamura S, Kawauchi K, et al. An Asian variant of intravascular large B-cell lymphoma: clinical, pathological and cytogenetic approaches to diffuse large B-cell lymphoma associated with haemophagocytic syndrome. Br J Haematol. 2000;111:826-834.
5. Gatter KC, Warnke RA. Diffuse large B-cell lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization: Pathology and Genetics of Tumors of Heamatopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:171-174.
6. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403:503-511.
7. Berglund M, Thunberg U, Amini RM, et al. Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis. Mod Pathol. 2005;18:1113-1120.
8. De Paepe P, Achten R, Verhoef G, et al. Large cleaved and immunoblastic lymphoma may represent two distinct clinicopathologic entities within the group of diffuse large B-cell lymphomas. J Clin Oncol. 2005;23:7060-7068.
9. + diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients. Blood. 2002;99:815-821.
10. Tagawa H, Tsuzuki S, Suzuki R, et al. Genomewide array-based comparative genomic hybridization of diffuse large B-cell lymphoma: comparison between CD5-positive and CD5-negative cases. Cancer Res. 2004;64:5948-5955.
11. Kanda M, Suzumiya J, Ohshima K, Tamura K, Kikuchi M. Intravascular large cell lymphoma: clinicopathological, immuno-histochemical and molecular genetic studies. Leuk Lymphoma. 1999;34:569-580.
12. Yegappan S, Coupland R, Arber DA, et al. Angiotropic lymphoma: an immunophenotypically and clinically heterogeneous lymphoma. Mod Pathol. 2001;14:1147-1156.
13. Estalilla OC, Koo CH, Brynes RK, Medeiros LJ. Intravascular large B-cell lymphoma; a report of five cases initially diagnosed by bone marrow biopsy. Am J Clin Pathol. 1999;112:248-255.
14. Kagami Y, Suzuki R, Taji H, et al. Nodal cytotoxic lymphoma spectrum: a clinicopathologic study of 66 patients. Am J Surg Pathol. 1999;23:1184-1200.
15. Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103:275-282.
16. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med. 1993;329:987-994.
17. Ferreri AJ, Campo E, Ambrosetti A, et al. Anthracycline-based chemotherapy as primary treatment for intravascular lymphoma. Ann Oncol. 2004;15:1215-1221.
18. Wick MR, Mills SE, Scheithauer BW, Cooper PH, Davitz MA, Parkinson K. Reassessment of malignant "angioendotheliomatosis": evidence in favor of its reclassification as "intravascular lymphomatosis." Am J Surg Pathol. 1986;10:112-123.
19. DiGiuseppe JA, Nelson WG, Seifter EJ, Boitnott JK, Mann RB. Intravascular lymphomatosis: a clinicopathologic study of 10 cases and assessment of response to chemotherapy. J Clin Oncol. 1994;12:2573-2579.
20. Ferreri AJ, Campo E, Seymour JF, et al. Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the 'cutaneous variant'. Br J Haematol. 2004;127:173-183.
21. Murase T, Suzuki R, Yamaguchi M, et al. High incidence of Asian variant intravascular large B-cell lymphoma (IVL) among IVL in Japan: clinicopathologic study of 95 patients [abstract]. Blood. 2004;104:383a.
22. Takahashi N, Miura I, Chubachi A, Miura AB, Nakamura S. A clinicopathological study of 20 patients with T/natural killer (NK)-cell lymphoma-associated hemophagocytic syndrome with special reference to nasal and nasal-type NK/T-cell lymphoma. Int J Hematol. 2001;74:303-308.
23. Oshimi K, Kawa K, Nakamura S, et al. NK-cell neoplasms in Japan. Hematology. 2005;10:237-245.
24. Kanda M, Suzumiya J, Ohshima K, et al. Analysis of the immunoglobulin heavy chain gene variable region of intravascular large B-cell lymphoma. Virchows Arch. 2001;439:540-546.
25. Ito M, Kim Y, Choi JW, Ozawa H, Fujino M. Prevalence of intravascular large B-cell lymphoma with bone marrow involvement at initial presentation. Int J Hematol. 2003;77:159-163.
26. Vieites B, Fraga M, Lopez-Presas E, Pintos E, Garcia-Rivero A, Forteza J. Detection of t(14;18) translocation in a case of intravascular large B-cell lymphoma: a germinal centre cell origin in a subset of these lymphomas? Histopathology. 2005;46:466-468.